chrisvoncsefalvay/vaers-outcomes huggingface dataset:
don't have any taste in my mouth/ no taste; nose runs; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), in 2021 as dose number unkown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: AGEUSIA (non-serious), outcome "unknown", described as "don't have any taste in my mouth/ no taste"; RHINORRHOEA (non-serious), outcome "unknown", described as "nose runs".  Additional information: The patient had the shots over a year ago. The patient had no taste since the shot for over 8 months and his nose runs. The patient's wife thought maybe it was covid. The patient had limburger cheese and can't taste it. The patient was asking how come he don't have any taste in his mouth for over a year and he can barely taste a lemon.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
1st dose 2 years ago, 2nd never; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received 1st dose on an unknown date, 2 years before date of reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 27-JAN-2023 Reporter's Comments: The reporter reported the case via interactive digital media. The patient received her/ his first Shingrix shot 2 years ago. The reporter asked could he/she take her/ his second shot now or did she/he need to take the first shot again. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Narrative:  Patient received Moderna Covid #1 on 2/27/21. No notes or scanned records to indication what happened between that date and date of death on 3/23/21. He was however on chemotherapy with ruxolitinib (Jakafi) for polycythemia. No autopsy report available. Time from vaccine to date of death was 24 days.
Patient returned to the pharmacy after receiving Flucelvax PF on 09/22/2021 and reported that she had to go to the ER due to anaphylactic reaction. DR prescribed her Epipen for future events
flu like symptoms; sore injection site arm; red area around the injection site.; This spontaneous case was reported by a patient family member or friend and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), VACCINATION SITE PAIN (sore injection site arm) and VACCINATION SITE ERYTHEMA (red area around the injection site.) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), VACCINATION SITE PAIN (sore injection site arm) and VACCINATION SITE ERYTHEMA (red area around the injection site.). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), VACCINATION SITE PAIN (sore injection site arm) and VACCINATION SITE ERYTHEMA (red area around the injection site.) outcome was unknown.            No concomitant medications were reported. The reporter stated that the patient received the vaccine and had not got COVID-19, believes this was because his daughter received the Moderna COVID-19 primary series and her two booster doses. The caller did not have any information on his daughters vaccinations. No lot numbers dates of vaccination or other adverse reactions were known.  Treatment information was unknown.   This case was linked to MOD-2022-614419, MOD-2022-614955, MOD-2022-614959 (Patient Link).
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY
This spontaneous report as received from a registered nurse via field representative refers to an adult male patient of unknown age. On an unknown date the patient was vaccinated with COMVAX (lot #, expiration date, dose, route of administration not provided), which is other-than-indicated int he prescribing information, instead of RECOMBIVAX HB, due to product confusion. No concomitant medications were reported. Additional information has been requested.
Given on 6/4/16. Side effects started 6/4 (evening) - red. On 6/5 (morning) - aching and swollen, continued to swell (hurting from shoulder to finger tips).
Person complained of feeling faint, appeared pale, diaphoretic, nauseated.  BP 97/67.  Wafer snack provided.  Person stated BP was always low.  Checked by EMS.  Condition Improved.  Discharged.
On June 19, 2022 I took a home COVID-19 test that came back negative but the next day I was not feeling so well and had a small cough. I tested again and this time it came back positive. I called my doctor and did a telehealth visit. She did not prescribe anything and said unless my symptoms got worse she felt my body would fight it off. I just have a dry cough, not coughing up anything, slight fever. By June 25, 2022 I was testing negative for COVID-19, currently I only have a dry cough.
Circular red, slightly itchy, hot, hard red bump on injection site. Reports it started to go down after three days. It is still a bit tender but not as concerning.
I had an earache that radiated behind my ear on my head. After several hours, I went to the ER. I was told that I probably had an ear infection and was given a Z=pack. A few days later, I had a horrible cough which I think I got from my son. I had no fever and I didn't lose my sense of taste. When the cough didn't go away, I had a telehealth appointment with my primary doctor on January 5, 2022 and was given a steroid for six days. I had a covid test the following day, which was negative. It took me about three weeks to totally get rid of the cough, but this isn't unusual for me.
Refridgeration excursions identified; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified).    Vaccination time given as 03:02 PM , anatomical location given as deltoid and Dose volume given as 0.5. Dose 1, 2 and 3 given by intramuscular and on deltoid. Concomitant medication not reported. Treatment medication not reported.
In May 2022, my 6-year-old child and I both received a  Pfizer covid shot (my 3rd, his 1st), while I was 7 months pregnant. I delivered a healthy baby, 8 lbs 9 oz.  In September, about 3-4 months after vaccine, I started getting cold urticaria (hives in cold weather). About 6-12 months after that, I started getting hyperthyroid symptoms (insomnia, tingling in arms, sugar cravings, irritability, etc.) and was diagnosed with Graves disease in August of 2023. In June 2023, my child was diagnosed with juvenile arthritis. Both are autoimmune conditions that developed around the same time as each other.
Tingling, muscle cramps/twitching in different areas of the body that is still persistent
Patient received Moderna as their 1st booster dose and still contracted COVID-19.; Lack of effect; This spontaneous case was reported by a non-health professional and describes the occurrence of COVID-19 (Patient received Moderna as their 1st booster dose and still contracted COVID-19.) and DRUG INEFFECTIVE (Lack of effect) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Patient received Moderna as their 1st booster dose and still contracted COVID-19.) and DRUG INEFFECTIVE (Lack of effect). At the time of the report, COVID-19 (Patient received Moderna as their 1st booster dose and still contracted COVID-19.) and DRUG INEFFECTIVE (Lack of effect) outcome was unknown.            No concomitant and treatment medication were provided.  It was reported that patient did not heard anything new and got very little COVID news anymore. Further it was reported that patient had COVID despite doing everything patient could to prevent it.  Company comment: This spontaneous case concerns a female patient of about 6 decades old, with no reported medical history, who experienced the non-serious unexpected AESI of COVID 19 which occurred unknown days after administration of third dose of mRNA-1273.222 bivalent vaccine. Drug ineffective was also reported as an event. Further details are not mentioned in the report. The benefit-risk relationship of mRNA-1273.222 bivalent vaccine, is not affected by this report.; Sender's Comments: This spontaneous case concerns a female patient of about 6 decades old, with no reported medical history, who experienced the non-serious unexpected AESI of COVID 19 which occurred unknown days after administration of third dose of mRNA-1273.222 bivalent vaccine. Drug ineffective was also reported as an event. Further details are not mentioned in the report. The benefit-risk relationship of mRNA-1273.222 bivalent vaccine, is not affected by this report.
I exp severe abdominal pain around March 15 which led to diagnosis of abscess of worsening Crohn's disease. I have a followed up CT scan next week to determine if surgery is needed.
A week after the second dose I had pain around my heart and under my left breast. Which lead me to go to the ER. Still have this pain.
I was having a sore throat in the evenings and really noticed it on Monday and Tuesday of this week. On Wednesday I was feeling worse, I was cold coughing and really feeling fatigued. I did take a home test and that came back negative. On Thursday my husband tested positive for COVID-19 so I tested again that day and it was also positive. I then reached out to my Doctor as well as I am pregnant. I am still recovering as this has all occurred this week.
On 30 October she received her seasonal influenza vaccine (GSK quadrivalent) in her left deltoid and noted immediate bleeding from the site. Later that day as she removed the bandage she noted bruising above the vaccination site. She denies easy bruising, bleeding, heavy menses, bloody urine, and blood in her stools. She denies known trauma to her deltoid other than the vaccination. Later that day she noted onset of intermittent NBNB vomiting and episodes of watery diarrhea alternating with formed stools which has persisted until today (four days total). She denies rhinoconjunctival, lip/tongue/oral/laryngeal, pulmonary, neurologic, and CV symptoms. She denies flushing, itching, and hives. She denies cutaneous symptoms other than bruise adjacent to vaccination site. She denies fever/chills and painful/swollen joints. She admits to taking Ibuprofen 800mg two days prior to receiving her influenza vaccine but otherwise denies medications and supplements. She denies a prior history of adverse reaction to vaccines, to include influenza.
extreme increases in urine/woke up to void 7 times/During the day had to void approximately each hour; This spontaneous case was reported by a consumer and describes the occurrence of POLYURIA (extreme increases in urine/woke up to void 7 times/During the day had to void approximately each hour) in a 67-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. 203e23a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Sep-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) .5 milliliter. On 23-Sep-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced POLYURIA (extreme increases in urine/woke up to void 7 times/During the day had to void approximately each hour). At the time of the report, POLYURIA (extreme increases in urine/woke up to void 7 times/During the day had to void approximately each hour) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) was unknown.       No concomitant medications were reported. It was unknown if the patient experienced any additional symptoms/events.  No treatment medications were provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-741814 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-741814:Same reporter, same product, different patient (spouse)
Per MD report, patient began experiencing arthritic symptoms in both wrists which started in the weeks after flu shot. MD states that patient now has early rheumatoid arthritis in both wrists. MD to contact physician at another hospital.  Dosage administered by medical center.
Pt received Moderna vaccine for dose #2,  but pt should have received the Pfizer vaccine to complete his COVID vaccine series.
17 y/o 1st dose pfizer vaccine received at 10:08am. stated he was nauseous and said he ate nothing this morning - his mom was present - she said nausea is normal for him - he drank water and took his vs at 10:25am, bp 110/80 54p 98.1 temp 98%pox - pfizer given in right arm, lot number er8729 first dose.
pt recvd vax 5MAR93 & devel a fever of 012, swollen glands in neck & an unspecified problem w/joints, sleepiness & a h/a; No further details were provided;
I got an RSV shot on September 8th and for the first few days I was tired and my joints were hurting. I thought it was a reaction and it was going to go away but it didn't. I started feeling numbness and tingling on the left side of my body where I got the shot (face, hand, leg). It is still there, not all the time but every day.
This spontaneous case was reported by a physician and describes the occurrence of CANDIDA INFECTION (the reaction "looks like thrush"/reaction in her mouth like thrush), TONGUE ERUPTION (rash on tongue), TONGUE DISCOMFORT (tongue burning) and TONGUE PRURITUS (Tongue is itching) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 071F21A and 048F21A) for COVID-19 vaccination. The patient's past medical history included Oral surgery. Concurrent medical conditions included Allergy to antibiotic and Thrush (The reaction had happened in the past with antibiotics.). On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced CANDIDA INFECTION (the reaction "looks like thrush"/reaction in her mouth like thrush), TONGUE ERUPTION (rash on tongue), TONGUE DISCOMFORT (tongue burning) and TONGUE PRURITUS (Tongue is itching). The patient was treated with BAPTISIA TINCTORIA, BENZOIC ACID, BORIC ACID, CINEOLE, ETHANOL, MENTHOL, METHYL SALICYLATE, THYMOL (LISTERINE [BAPTISIA TINCTORIA;BENZOIC ACID;BORIC ACID;CINEOLE;ETHANOL;MENTHOL;METHYL SALICYLATE;THYMOL]) at an unspecified dose and frequency. At the time of the report, CANDIDA INFECTION (the reaction "looks like thrush"/reaction in her mouth like thrush) had not resolved and TONGUE ERUPTION (rash on tongue), TONGUE DISCOMFORT (tongue burning) and TONGUE PRURITUS (Tongue is itching) was resolving. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient was a retired physician. The patient never had COVID positive test or diagnosis. The patient received unspecified antibiotics that were given within 1 month prior to Moderna COVID-19 vaccine. The patient received both the doses on left arm non-dominant. The patient had mouth burning sensation and tongue became yellow and white in color. The patient reported that she "drove dentist crazy" with questions. As per the patient, she took numerous amounts of medicine and not sure what to rule out. It went away only by using Listerine constantly. The patient went to see the oral specialist and several other doctors, but they cannot figure it out. The patient had 9 teeth pulled and now was going through recovery with tongue. Also, the patient would go for oral surgery again, so would like to figure out what it was.
Immediately after injection of Kinrix, child became rigid, eyes rolled back, blue around mouth and had jerking of both arms- lasting approximately 60 seconds. Placed on left side, vital signs monitored, became responsive within 3 minutes. Child observed x 45 minutes without further incident. Mother advised to see physician or urgent care facility for follow- up today.
NauseaVomiting Chills, Joint pain, Loss of appetite, and her inside feeling hot. Narrative:
Fever and chills, nausea.  On 03/15/2015 - symptoms continued and worsened, diarhea began.  Took aspirin.  Drank gatorade.  Blood in urine began along with great difficulty in urination.  Onset of UTI.  03/16/2015 - fever broke, continued with aspirin, began taking OTC drug AZO whcih began to aid in the UTI relief after some time.  03/17/2015 - Able to get to URgent Care facility to be seen by Dr.   Urine Test indicated UTI.  Prescribed Doxycycline.  03/20/2015 - Dr.  confirmed UTI, continued on Doxy.  Also discovered BPH.  This may have been aggrevated by vaccines and UTI.  Dr. did not have an answer as to how I contraced UTI.  Gave me the go-ahead for out of country trip.  Doxy was able to keep the UTI at bay but not knock it out.  After returning, another urologist put me on Cipro which did get rid of the UTI.  Also put on Tamsulosin.  Dr.
Hives within the first 24 hours, post vax. Parent did not call office so nothing was done. Subsided in 48 hours.
11cm X 7cm red induration with moderate tenderness, warm to touch. Injections were given 6/12/06.
The patient developed a high fever and muscle aches 24 hours after being given the vaccine. It lasted for 2 days. On the third day she developed an inflamed, red arm at the injection site. She went to the doctor and have her an antibiotic and told her to take benadryl for her arm.
Individual reported symptoms of cough, SOB, congestion, sore throat, and while blisters/pustules in her mouth since 12/8/21. She tested Covid positive on 12/9/21. She continues to remain isolated at home (lives alone) for 10 days. She will contact a provider today to make a telehealth appointment. Individual will notify Mgmt and to callback Covid hotline for follow up. Infection Control notified.
No additional AE; Patient was inadvertently administered a dose of MMR II on 12/10/2021 with a labeled expiry of 11/20/2021; This spontaneous report was received from a medical assistant referring to a patient of unreported age and gender. The patient's pertinent medical history, concomitant therapies, and previous drug reactions or allergies were not reported.  On 10-DEC-2021, the patient was inadvertently vaccinated with a labelled expiry of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), 0.5 ml (milliliter) for prophylaxis (expired product administered) (lot number S037499 has been verified to be a valid lot number, the expiration date was reported and established as 20-NOV-2021; dose number, vaccination scheme, route of administration and anatomical site of vaccination were not reported).   No additional AE was reported.  No temperature excursion was reported
Sialadenitis (salivary gland inflammation); glossitis (tounge inflammation); inflammation of the mucosal lining of the oral cavity with cherry red discoloration and swelling of the lips; inflammation of the mucosal lining of the oral cavity with cherry red discoloration and swelling of the lips; inflammation of the mucosal lining of the oral cavity with cherry red discoloration and swelling of the lips; Tingling; prickly sensation on tongue when eating; cold items felt opposite of what they should, more like burning sensation; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6202), via an unspecified route of administration in the left arm on 27Feb2021 12:45 as single dose for COVID-19 immunization. Medical history included known allergies to Sulph. The patient was not pregnant. Concomitant medications included aceclofenac (BIOFLEX [ACECLOFENAC]), calcium (CITRICAL [CALCIUM]) and vitamin D (VITAMIN D [VITAMIN D NOS]). On 01Mar2021 08:00, the patient experienced sialadenitis (salivary gland inflammation), glossitis (tounge inflammation), inflammation of the mucosal lining of the oral cavity with cherry red discoloration and swelling of the lips. Tingling, prickly sensation on tongue when eating, cold items felt opposite of what they should, more like burning sensation were also reported. Onset of symptoms Monday morning, symptoms peaked Wednesday evening through midday Thursday, greatly improved by Friday morning. The patient had a COVID test on Friday to be sure and it was negative. There were no treatment for events. No COVID prior vaccination. The patient had a COVID test type post vaccination-Nasal Swab (Covid 2 PCR) on 05Mar2021 which was negative. The patient had The outcome of the events was recovered on unspecified date in Mar2021.
After getting the shot I felt feverish, chills, migraines/headaches, nauseated, swollen lymph nodes only under the armpit on the right side, tender arm, weaknesses in arm, cracking noises in shoulder and neck, neck aches, some tingling in arm
Patient age was overlooked and he received a second bivalent booster even though he was only 62 years old. He was glad to have gotten it and we only realized that he should not have gotten it when he returned with his wife because she wanted it also and we said she was too young.  We followed up with patient at 1 and 5 days afterwards and he said he had no adverse reactions to the vaccine.